Tranexamic acid reduces endometrial cancer effects through the production of angiostatin.

Angiostatin Endometrial cancer Macrophages Plasminogen Tranexamic acid

Journal

Journal of Cancer
ISSN: 1837-9664
Titre abrégé: J Cancer
Pays: Australia
ID NLM: 101535920

Informations de publication

Date de publication:
2022
Historique:
received: 18 10 2021
accepted: 23 01 2022
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 5 4 2022
Statut: epublish

Résumé

Tranexamic acid (TA) has been reported to exhibit antitumor effects in various mouse models of cancer. However, the mechanism underlying its antitumor effects against endometrial cancer remains to be elucidated. This study was aimed at investigating the efficacy of TA against chronic inflammation-associated endometrial cancer induced by

Identifiants

pubmed: 35371322
doi: 10.7150/jca.68169
pii: jcav13p1603
pmc: PMC8965126
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1603-1610

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Cell. 1997 Mar 21;88(6):801-10
pubmed: 9118223
Cell Rep. 2017 Nov 28;21(9):2471-2486
pubmed: 29186685
FASEB J. 1998 Dec;12(15):1731-8
pubmed: 9837863
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2930-5
pubmed: 8610145
Biol Pharm Bull. 2015;38(6):947-50
pubmed: 26027838
Cardiovasc Res. 2005 Feb 15;65(3):550-63
pubmed: 15664381
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10868-72
pubmed: 9380726
Clin Exp Dermatol. 2016 Jul;41(5):480-5
pubmed: 27135282
Endocr Rev. 2004 Aug;25(4):581-611
pubmed: 15294883
Pharmacology. 2020;105(11-12):652-661
pubmed: 32348988
Cancer Res. 1996 Nov 1;56(21):4887-90
pubmed: 8895739
J Clin Invest. 2004 Sep;114(5):623-33
pubmed: 15343380
Biomed Pharmacother. 2016 May;80:16-22
pubmed: 27133035
J Biol Chem. 1997 Sep 5;272(36):22924-8
pubmed: 9278456
Physiol Rev. 1993 Jan;73(1):161-95
pubmed: 8419965
Cell. 1994 Oct 21;79(2):315-28
pubmed: 7525077
Biomed Res Int. 2018 Nov 6;2018:1683414
pubmed: 30533427
Exp Dermatol. 2014 Sep;23(9):659-63
pubmed: 25041031
J Biol Chem. 1996 Nov 15;271(46):29461-7
pubmed: 8910613
J Surg Res. 2017 Jul;215:47-54
pubmed: 28688660

Auteurs

Keiichi Hiramoto (K)

Department of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.

Yurika Yamate (Y)

Department of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.

Classifications MeSH